Ikarian Capital, LLC Axsome Therapeutics, Inc. Call Options Transaction History

Ikarian Capital, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 15, 2023	BUY	$58.39 - $75.0 $8.76 Million - $11.3 Million	150,000 New	150,000 $9.25 Million
Q2 2022 Aug 12, 2022	BUY	$21.74 - $46.75 $7.61 Million - $16.4 Million	350,000 New	350,000 $13.4 Million
Q3 2020 Nov 16, 2020	SELL	$68.34 - $85.84 $1.25 Million - $1.57 Million	-18,300 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$49.87 - $98.69 $17.8 Million - $35.2 Million	-356,700 Reduced 95.12%	18,300 $1.51 Million
Q1 2020 May 15, 2020	BUY	$41.2 - $101.31 $15.5 Million - $38 Million	375,000 New	375,000 $22.1 Million

325

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.64B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.